Sage Journals: Discover world-class research

Open access

Research article

First published 2023-5

Defining migraine days,based on longitudinal E-diary data

Britt W. H. van der Arend, Iris E. Verhagen, Matthijs van Leeuwen [...]

Cephalalgia

Open access

Research article

First published 2022

Rimegepant 75 mg for acute treatment of migraine is associated with significant reduction in monthly migraine days: Results from a long-term,open-label study

Gilbert L’Italien, Evan Popoff, Karissa Johnston [...]

Cephalalgia Reports

Open access

Research article

First published 2023-9

Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study

Britt W. H. van der Arend, Mirthe M. Bloemhof, Alle G. van der Schoor [...]

Cephalalgia

Free access

Review article

First published 2020-1

Problematic presentation and use of efficacy measures in current trials of CGRP monoclonal antibodies for episodic migraine prevention: A mini-review

Peer Tfelt-Hansen, Hans-Christoph Diener, Timothy J Steiner

Cephalalgia

Open access

Research article

First published 2025-10

Efficacy and safety of eptinezumab in a predominantly Asian population with chronic migraine: Results of the randomized,double-blind,placebo-controlled SUNRISE trial

Shengyuan Yu, Yasuhiko Matsumori, Byung-Kun Kim [...]

Cephalalgia

Open access

Research article

First published 2020

Economic burden of migraine in Singapore

Jonathan Jia Yuan Ong, Devanshi Patnaik, Yee Cheun Chan [...]

Cephalalgia Reports

Free access

Research article

First published 2020-1

The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%,≥75%,and 100% response

Jan Lewis Brandes, Hans-Christoph Diener, David Dolezil [...]

Cephalalgia

Retricted access

Review article

First published 2019-9

Erenumab: A First-in-Class Monoclonal Antibody for Migraine Prevention

Scott G. Garland, Steven M. Smith, John G. Gums

Annals of Pharmacotherapy

Open access

Research article

First published 2025

Galcanezumab-induced psoriasis-like lesions of the eyebrows: A case report and review of CGRP's role in cutaneous inflammation

Patricia Díaz-Corta, Sergio Campoy, Lidia Termens [...]

Cephalalgia Reports

Open access

Research article

First published 2025-11

A phase 4,randomized,double-blind,placebo-controlled trial evaluating the efficacy and tolerability of rimegepant for the prevention of episodic migraine in adults with a history of inadequate response to traditional oral preventive medications

Patricia Pozo-Rosich, José Antonio Gien López, Pawel Lisewski [...]

Cephalalgia

Search results